Krishna Vaddadi

2.2k total citations
42 papers, 1.7k citations indexed

About

Krishna Vaddadi is a scholar working on Psychiatry and Mental health, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Krishna Vaddadi has authored 42 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Psychiatry and Mental health, 8 papers in Physiology and 7 papers in Cellular and Molecular Neuroscience. Recurrent topics in Krishna Vaddadi's work include Schizophrenia research and treatment (14 papers), Diet and metabolism studies (7 papers) and Genetic Neurodegenerative Diseases (6 papers). Krishna Vaddadi is often cited by papers focused on Schizophrenia research and treatment (14 papers), Diet and metabolism studies (7 papers) and Genetic Neurodegenerative Diseases (6 papers). Krishna Vaddadi collaborates with scholars based in Australia, United Kingdom and Ireland. Krishna Vaddadi's co-authors include A.I.M. Glen, D.F. Horrobin, David F. Horrobin, Chris Gilleard, Mitchell W. Spellman, E.M.T. Glen, N. M. Fisher, Mehar S. Manku, Kelsey A. Ellis and John L. Bradshaw and has published in prestigious journals such as Neurology, Biological Psychiatry and Neuroscience.

In The Last Decade

Krishna Vaddadi

42 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Krishna Vaddadi Australia 23 523 473 462 455 377 42 1.7k
A.I.M. Glen United Kingdom 20 539 1.0× 689 1.5× 470 1.0× 326 0.7× 286 0.8× 45 2.2k
Mehdi Farokhnia United States 33 508 1.0× 583 1.2× 579 1.3× 354 0.8× 483 1.3× 95 2.9k
Denise R. Evans United States 12 223 0.4× 490 1.0× 186 0.4× 196 0.4× 301 0.8× 15 1.3k
Trino Baptista Venezuela 30 422 0.8× 1.4k 3.0× 936 2.0× 136 0.3× 455 1.2× 105 2.9k
Therese Rider United States 22 378 0.7× 203 0.4× 627 1.4× 934 2.1× 143 0.4× 39 1.7k
Kevin E. Stanford United States 23 237 0.5× 990 2.1× 604 1.3× 275 0.6× 134 0.4× 30 2.1k
Sukdeb Mukherjee United States 27 355 0.7× 1.8k 3.8× 340 0.7× 224 0.5× 305 0.8× 84 3.1k
Yuly Bersudsky Israel 27 390 0.7× 916 1.9× 202 0.4× 85 0.2× 317 0.8× 89 1.8k
Murat Kuloğlu Türkiye 24 206 0.4× 677 1.4× 310 0.7× 162 0.4× 171 0.5× 68 2.0k
Roger Desnyder Belgium 15 241 0.5× 459 1.0× 257 0.6× 363 0.8× 235 0.6× 17 2.0k

Countries citing papers authored by Krishna Vaddadi

Since Specialization
Citations

This map shows the geographic impact of Krishna Vaddadi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Krishna Vaddadi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Krishna Vaddadi more than expected).

Fields of papers citing papers by Krishna Vaddadi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Krishna Vaddadi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Krishna Vaddadi. The network helps show where Krishna Vaddadi may publish in the future.

Co-authorship network of co-authors of Krishna Vaddadi

This figure shows the co-authorship network connecting the top 25 collaborators of Krishna Vaddadi. A scholar is included among the top collaborators of Krishna Vaddadi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Krishna Vaddadi. Krishna Vaddadi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vaddadi, Krishna, et al.. (2010). Are we using excessive neuroleptics? An argument for systematic neuroleptic dose reduction in stable patients with schizophrenia with specific reference to clozapine. International Review of Psychiatry. 22(2). 138–147. 11 indexed citations
2.
Vaddadi, Krishna. (2010). Rehabilitation psychiatry: Moving forward. International Review of Psychiatry. 22(2). 95–98. 2 indexed citations
3.
Puri, Basant K., Blair R. Leavitt, Michael R. Hayden, et al.. (2005). Ethyl-EPA in Huntington disease. Neurology. 65(2). 286–292. 115 indexed citations
4.
Das, Undurti N. & Krishna Vaddadi. (2004). Essential fatty acids in Huntington's disease. Nutrition. 20(10). 942–947. 21 indexed citations
5.
Rogers, Mark A., John L. Bradshaw, James G. Phillips, & Krishna Vaddadi. (2002). Attentional asymmetries following ECT in patients with major depression. Neuropsychologia. 40(3). 241–244. 5 indexed citations
6.
Vaddadi, Krishna, et al.. (2002). A randomised, placebo-controlled, double blind study of treatment of Huntington’s disease with unsaturated fatty acids. Neuroreport. 13(1). 29–33. 61 indexed citations
7.
Rogers, Mark A., et al.. (2002). Mental Rotation in Unipolar Major Depression. Journal of Clinical and Experimental Neuropsychology. 24(1). 101–106. 32 indexed citations
8.
Rogers, Mark A., et al.. (2000). Parkinsonian Motor Characteristics in Unipolar Major Depression. Journal of Clinical and Experimental Neuropsychology. 22(2). 232–244. 22 indexed citations
9.
Phillips, James G., et al.. (1998). Cue dependent right hemineglect in schizophrenia: a kinematic analysis. Journal of Neurology Neurosurgery & Psychiatry. 65(4). 454–459. 16 indexed citations
10.
Phillips, James G., et al.. (1998). Response programming in patients with schizophrenia: A kinematic analysis. Neuropsychologia. 36(7). 603–610. 6 indexed citations
11.
Phillips, James G., et al.. (1997). Kinematic analysis of handwriting movements in Schizophrenic patients. Biological Psychiatry. 41(7). 830–833. 32 indexed citations
12.
Vaddadi, Krishna. (1996). Stress of Caregiving for the Chronically Mentally Ill. Psychiatric Annals. 26(12). 766–771. 6 indexed citations
13.
Vaddadi, Krishna, et al.. (1996). Schizophrenia, tardive dyskinesia and essential fatty acids. Schizophrenia Research. 20(3). 287–294. 34 indexed citations
14.
Glen, A.I.M., et al.. (1996). Membrane fatty acids, niacin flushing and clinical parameters. Prostaglandins Leukotrienes and Essential Fatty Acids. 55(1-2). 9–15. 81 indexed citations
15.
Vaddadi, Krishna. (1996). Dyskinesias and their treatment with essential fatty acids: a review. Prostaglandins Leukotrienes and Essential Fatty Acids. 55(1-2). 89–94. 26 indexed citations
16.
Glen, A.I.M., E.M.T. Glen, David F. Horrobin, et al.. (1994). A red cell membrane abnormality in a subgroup of schizophrenic patients: evidence for two diseases. Schizophrenia Research. 12(1). 53–61. 204 indexed citations
17.
Vaddadi, Krishna. (1992). Use of gamma-linolenic acid in the treatment of schizophrenia and tardive dyskinesia. Prostaglandins Leukotrienes and Essential Fatty Acids. 46(1). 67–70. 20 indexed citations
18.
Vaddadi, Krishna, et al.. (1989). A double-blind trial of essential fatty acid supplementation in patients with tardive dyskinesia. Psychiatry Research. 27(3). 313–323. 97 indexed citations
19.
Horrobin, David F., Mehar S. Manku, N. M. Fisher, et al.. (1989). Essential fatty acids in plasma phospholipids in schizophrenics. Biological Psychiatry. 25(5). 562–568. 68 indexed citations
20.
Vaddadi, Krishna & Uddalak Das. (1988). HIV virus, prostaglandins and essential fatty acids; a suggested mechanism for T helper cell penetration. Medical Hypotheses. 26(4). 229–230. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026